The Emergence of Massive Open Online Courses (MOOC)

By Editorial Team -

Comments

Post a Comment

Popular posts from this blog

Best AI Stocks & ETFs for 2026: Powering the Next Boom

By -
Image
Updated October 7, 2026 · Originally published December 2025 · By the One Day Advisor Editorial Team Prices and year-to-date (YTD) figures are as of the October 6, 2026 close unless another date is shown. Figures marked “est.” are unconfirmed. Quick Answer AI infrastructure stocks hit record highs in early October 2026, but returns are uneven. Nvidia (about $240, up roughly 28% this year) and AMD (up roughly 190%) lead; the VanEck Semiconductor ETF (SMH) is up about 76%; Vertiv sits a third below its record. The key risk is rates: the Fed hiked on September 16 and the 10-year yield touched 5.31%. TSMC reports October 15; the Fed decides October 28. Disclosure: This article is educational and is not financial or investment advice. It contains no affiliate or sponsored links. Other One Day Advisor pages may include Amazon Associates links, which are disclosed wher...
Read more

Top 10 Food Companies by Revenue — 2026 Update

By -
Image
The 10 largest publicly traded food and beverage companies by full-year 2025 revenue are: Nestlé (~$115.4B), Ahold Delhaize (~$107B), PepsiCo ($93.9B), JBS ($86.2B), Sysco ($81.4B), ADM ($80.3B), Performance Food Group ($63.3B), Anheuser-Busch InBev ($59.3B), Unilever (~$58.5B), and Tyson Foods ($54.4B). Privately held Cargill (~$160B) and Mars (~$50B+) are excluded because they don't publish standardized public financials. The global food and beverage industry remains one of the largest and most resilient sectors of the world economy, generating trillions of dollars in annual revenue . While consumer preferences, inflation, GLP-1 drug demand shifts, and supply-chain realignments continue to reshape the market, a relatively small group of multinational corporations still dominate global food sales. This June  2026 update revises our rankings using confirmed full-year 2025 results...
Read more

Largest Pharma Companies in the World (2026 Revenue Rankings)

By -
Image
Based on full-year 2025 results and Q2 2026 earnings reported through early August 2026, Johnson & Johnson ($94.2 billion FY2025 revenue; 2026 guidance just raised to ~$101.1 billion) remains the world's largest pharmaceutical/healthcare company by revenue, followed by China's Sinopharm Group (~$80 billion, primarily a distributor), Roche (~$70 billion), Eli Lilly ($65.2 billion FY2025, +45%; Q2 2026 revenue jumped 47.7% YoY to $22.97 billion, guidance now raised to $85–87 billion), Merck & Co. ($65.0 billion; Q2 2026 guidance raised to $66.3–67.3 billion), Pfizer ($62.6 billion; guidance raised to $60.5–62.5 billion), AbbVie ($61.2 billion; Q2 2026 revenue up 10.2% to $16.99 billion, guidance raised to ~$67.6 billion), AstraZeneca ($58.7 billion), Novartis ($54.5 billion) and Bristol Myers Squibb ($48.2 billion) rounding out the top 10. By market capitalization, Eli Lilly is far ahead of every rival at roughly $1.12 trillion as of early August 2026 — more than Johnson ...
Read more